Ariad Narrows Geographic Reach To Maximize Commercial Resources
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech has been streamlining its operations through licensing deals and changing its R&D strategy to better reflect its new geographic makeup – moves that could make it attractive to buyers.